Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8318700
Lung-targeted drugs
granted patentUS 8318945
Metalloprotein inhibitors
granted patentUS 8318182
Vault compositions for immunization against Chlamydia genital infection
granted patentUS 8318906
EMP2 antibodies and their therapeutic uses
granted patentUS 8309525
Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration
granted patentUS 8309350
Photoreactive regulator of protein function and methods of use thereof
granted patentUS 8309355
Methods of treating Parkinson's disease using viral vectors
granted patentUS 8309565
Phosphonate compounds
granted patentUS 8304408
Wnt signaling inhibitors, and methods for making and using them
granted patentUS 8298606
Methods and compositions for stabilizing the myocardium
granted patentUS 8298521
Treatment for eye disorder
granted patentUS 8298556
Methods and related compositions for the non-surgical removal of fat
granted patentUS 8299218
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted patentUS 8299046
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage
granted patentUS 8293764
Compositions and methods for disruption of BRCA2-Rad51 interaction
granted patentUS 8287879
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods
granted patentUS 8283308
Copolymer-stabilized emulsions
granted patentUS 8277797
Interferon-Ξ² production modulating Listeria strains and methods for using same
granted patentUS 8273867
Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS
granted patentUS 8274643
Porous nanostructures and methods involving the same
granted patentUS 8263662
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
granted patentUS 8263661
Development of new selective estrogen receptor modulators
granted patentUS 8263651
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat
granted patentUS 8263133
Multivalent clustering targeting strategy for drug carriers
granted